Laguna Thrombectomy System
Commercial- Indications
- Peripheral vascular disease, Deep vein thrombosis, Pulmonary embolism
Company intelligence / Profile preview
Innova Vascular has received FDA clearance for its Laguna Clot Retriever System and Malibu Aspiration Catheter System—collectively known as the Laguna Thrombectomy System—for use in the peripheral vasculature. These devices are now commercially available and have been successfully used at major medical centers. The company recently entered an exclusive US distribution agreement with Varian, a Siemens Healthineers company.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innova Vascular.